Attention-deficit hyperactivity disorder cost-effectiveness of therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Charmaine Patel, M.D. [2]

Attention-deficit hyperactivity disorder Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Attention-Deficit Hyperactivity Disorder from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Criteria
History and Symptoms
Psychiatric Examination
Laboratory Findings
Imaging Findings
Treatment
Medical Therapy
Psychotherapy
Brain Stimulation Therapy
Cost-Effectiveness of Therapy
Monitoring Response to Therapy
Future or Investigational Therapies
Case Studies
Case #1
Template:Attention-deficit hyperactivity disorder On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Attention-deficit hyperactivity disorder cost-effectiveness of therapy All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Attention-deficit hyperactivity disorder cost-effectiveness of therapy
CDC on Attention-deficit hyperactivity disorder cost-effectiveness of therapy
Attention-deficit hyperactivity disorder cost-effectiveness of therapy in the news
Blogs on Attention-deficit hyperactivity disorder cost-effectiveness of therapy
Directions to Hospitals Treating Attention-deficit hyperactivity disorder
Risk calculators and risk factors for Attention-deficit hyperactivity disorder cost-effectiveness of therapy

Cost-Effectiveness of Treatment

Comorbid disorders or substance abuse can make finding the proper diagnosis and the right overall treatment more costly and time-consuming. Psychosocial therapy is useful in treating some comorbid conditions.